Single answer
Is Amphastar Pharmaceuticals Inc (AMPH) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $0.79 or -20.89%
(In 48 weeks 16 hours 30 minutes and 24 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Amphastar Pharmaceuticals Inc is $30.00, which is $3.00 (11.11%) above the current price today's price.
Low target: $30.00 | High target: $30.00
Company snapshot
A quick overview of the business and its public profile.
Amphastar Pharmaceuticals Inc a biopharmaceutical company develops manufactures markets and sells generic and proprietary injectable inhalation and intranasal products in the United States China and France The company operates through two segments Finished Pharmaceutical Products and API It offers Primatene Mist an overthecounter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma Enoxaparin a low molecular weight heparin to prevent and treat deep vein thrombosis Naloxone for opioid overdose Glucagon for injection emergency kit and Cortrosyn a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency The company also provides Amphadase a bovinesourced hyaluronidase injection to absorb and disperse other injected drugs Epinephrine injection for the emergency treatment of allergic reactions lidocaine jelly an anesthetic product for urological procedures lidocaine topical solution for various procedures phytonadione injection a vitamin K1 injection for newborn babies emergency syringe products for emergency use in hospital settings morphine injection for use with patient controlled analgesia pumps and lorazepam injection for surgery and medical procedures In addition it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants and Isoproterenol hydrochloride injection for mild or transient episodes of heart block Further the company distributes recombinant human insulin active pharmaceutical ingredients API and porcine insulin API It serves hospitals care facilities alternate care sites clinics and doctors offices The company was founded in 1996 and is headquartered in Rancho Cucamonga California
Website: https://www.amphastar.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.39. Cash flow to debt ratio: 0.23. Net profit margin: 15.43%. Inflation risk score: low (0.40/1).
Dividend history check
Yes, Amphastar Pharmaceuticals Inc pays dividends. Last payment was 2010-06-30 for holders on 2010-06-11. Over 2 payments between 2009 and 2010, total $0.600 with an average of $0.300 per share. Last dividend was $0.300.
Trading liquidity
Yes, the average daily trading liquidity for Amphastar Pharmaceuticals Inc is $12.5M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Amphastar Pharmaceuticals Inc, 2015-12-31 had a stock price of $14.23. If you invested back then, your return now would be a profit of $12.77 per share or 89.74%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.